Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial performance of a business entity when making investment ...

Financial analysts and individual investors can rely on the chain to gauge the stock's performance, monitor its activity, and see prices changes when making an investment decision. Test out Nasdaq ...

Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Should you invest $1,000 in Eli Lilly right now? Stock Advisor analyst team just identified what ...

This was the stock's fourth consecutive day of losses.

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Eli Lilly & Co. said Tuesday it’s cutting the ... loss drugs that had allowed for alternatives to be made, sending the stock of telehealth provider Hims & Hers Health Inc. sharply lower.